{"task_id": "ec4e8d514ea3b886", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 83/464)", "text": "SPECIAL\nrenal biopsy\n68\nAcute Renal Failure: Renal\n\n--- Page 90 ---\nDISTINGUISHING FEATURES BETWEEN VARIOUS RENAL ETIOLOGIES\nUrinalysis\nOther tests\nVascular\nBland\nUrinary eosinophils (cholesterol emboli)\nPeripheral smear (TTP)\np anca (PAN)\nANA, ENA (lupus)\nTubular\nMuddy brown casts (ATN)\nCK (rhabdomyolysis)\nUric acid (gout)\nInterstitial\nWBC casts, urinary eosinophils\nSystemic eosinophilia\nGlomerular\nRBC casts\nAcanthocyte (dysmorphic RBC)\nOval fat body\nFatty cast\nc anca (Wegener\u2019s)\np anca (PAN)\nEosinophilia (Churg Strauss)\nAnti GBM (Goodpasture\u2019s syndrome)\nANA, anti dsDNA (SLE)\nASO titer (PSGN)\nBlood C&S, echo (infectious endocarditis)\nHBV/HCV serology, SPE, UPE (multiple myeloma)\nCryoglobulins, rheumatoid factor\n(cryoglobulinemia)\nMANAGEMENT\nPREVENTION\navoid contrast dye, nephrotoxins\nif possible\nTREAT UNDERLYING CAUSE\nnephrotic syndrome\n(low salt diet and furosemide for volume regulation if\nneeded; statin if needed to correct hyperlipidemia)\nRENAL\nREPLACEMENT\ndialysis\n(peritoneal,\nhemodialysis)\nSPECIFIC ENTITIES\nPSEUDO RENAL\nFAILURE\ncimetidine\nand\ntri\nmethoprim may reduce tubular secretion of creati\nnine causing a small but significant increase in serum\ncreatinine in the absence of # GFR\nMULTIPLE MYELOMA AND RENAL FAILURE\n\u0002\nPRE-RENAL\nN&V, renal vein thrombosis, calcium\ninduced vasospasm, nephrogenic diabetes insipi\ndus (hypercalcemia)\n\u0002\nRENAL\nsecondary amyloidosis (l), light chain\ndeposition disease (k), myeloma kidney (tubuloin\nterstitial damage due to increased light chain\nabsorption\nthrough\nproximal\ntubule),\nBence\nJones/cast nephropathy, plasma cell infiltration,\ncryoglobulinemia, pyelonephritis, sepsis\n\u0002\nPOST-RENAL\nrenal stones (hypercalcemia), neuro\ngenic bladder\nNSAIDS INDUCED RENAL FAILURE\n\u0002\nPRE-RENAL\ninhibition of prostaglandin synthesis\nleading to afferent vasoconstriction, hypertensive\nnephropathy\n\u0002\nRENAL\nacute interstitial nephritis, nephrotic syn\ndrome (minimal change disease, membranous)\nACUTE TUBULAR NECROSIS (ATN)\n\u0002\nPATHOPHYSIOLOGY\ntubular damage ! decreased\nreabsorption\nof\nNa\n!\nvasoconstriction\n!\nSPECIFIC ENTITIES (CONT\u2019D)\ndecreased GFR. Also may be related to tubular\nblockage from damaged epithelial cells. Risk fac\ntors include elderly (GFR # by 1 mL/min/year after\nage 40), pre existing renal dysfunction, decreased\ncardiac function, diabetes, dehydration, and multi\nple nephrotoxins\n\u0002\nTREATMENTS\nafter the insults are stopped, may\nstart to recover in 3 5 days. Generally takes 7 21\ndays (some up to 8 weeks) for full recovery\nCONTRAST NEPHROPATHY\n\u0002\nPATHOPHYSIOLOGY\ncontrast induced vasospasm,\nhyperosmolar load and oxygen free radical gen\neration ! acute tubular injury ! \" Cr or # GFR by\n25%. Usually develops immediately after expo\nsure to contrast, peaks in 48 72 h. Risk factors\nand recovery time course same as ATN. Key dif\nferential diagnosis is renal atheroemboli after\narterial catheterization (usually delayed onset of\nrenal failure and may see other signs of arterial\nischemia)\n\u0002\nRISK FACTORS\npatient risk factors (pre existent\nrenal failure, multiple myeloma, diabetes mellitus,\nhypertension, volume contraction, HF, exposure to\nnephrotoxins such as NSAIDs or aminoglycosides,\nrecent acute coronary syndrome), procedural risk\nfactors (increased dye load, increased osmolar dye\nload)\n\u0002\nPREVENTION\navoid contrast dye, nephrotoxins,\nand volume depletion if possible. If contrast abso\nlutely required, use low (iohexol) or iso osmolal\n(iodixanol) non ionic agents. Hydration options\ninclude (1) IV 1/2 NS at 1 mL/kg/h starting 12 h\nbefore until 12 h after contrast exposure; (2) IV NS\nor NaHCO3 154 mmol/L at 3 mL/kg/h starting 1 h\nINVESTIGATION ISSUES\nAcute Renal Failure: Renal\n69", "text_length": 3647, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 83/464)", "type": "chunk", "chunk_index": 82, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.354188", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.354895", "status": "complete", "chunks_added": 2}